Am J Clin Nutr 84(5):10271032 Yu Z-G, Jia C-X, Liu L-Y, Geng C-Z, Tang J-H, Zhang J, Zhang Q, Li Y-Y, Ma Z-B (2012) The prevalence and correlates of breast cancer among women in Eastern China
[18] Hornberger K R, Araujo E M V
Clinical trials demonstrate that this gradual approach balances tolerability with weight loss efficacy, reducing gastrointestinal side effects while maintaining therapeutic benefit
The body mass index (BMI) is often used in epidemiological research to identify overweight and obesity, although it has limited sensitivity due to considerable inter-individual variability in the percentage of body fat, which is partially based on age, gender, and ethnicity
Weight loss is only part of it
External resources ScienceDirect: Impact of injection sites on subcutaneous peptide pharmacokinetics NEJM: Once-weekly semaglutide in adults with overweight or obesity For researchers serious about optimizing every aspect of their GLP-1 protocol, SeekPeptides offers the most comprehensive resource available, with evidence-based injection guides, personalized protocol builders, and a community of thousands who have navigated these exact questions